Chimin Health Management Co., Ltd. (SHA:603222)
China · Delayed Price · Currency is CNY 10.15
-0.27 (-2.59%)
May 8, 2026, 3:00 PM CST
Chimin Health Management Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 668.04 | 685.96 | 768.99 | 891.24 | 835.22 | 1,095 |
Other Revenue | - | - | 6.74 | 3.27 | 2.02 | 3.86 |
| 668.04 | 685.96 | 775.73 | 894.51 | 837.24 | 1,098 | |
Revenue Growth (YoY) | -7.63% | -11.57% | -13.28% | 6.84% | -23.78% | 25.16% |
Cost of Revenue | 468.28 | 472.97 | 496.13 | 515.7 | 451.04 | 572.59 |
Gross Profit | 199.76 | 212.99 | 279.6 | 378.81 | 386.2 | 525.88 |
Selling, General & Admin | 248.67 | 251.04 | 276.71 | 293.6 | 258.96 | 268.9 |
Research & Development | 45.28 | 47.92 | 41.61 | 28.9 | 28.38 | 30 |
Other Operating Expenses | 8.78 | 8.35 | 9.78 | 9.96 | 11.64 | 13.64 |
Operating Expenses | 302.73 | 307.31 | 324.53 | 341.92 | 299.92 | 316.72 |
Operating Income | -102.97 | -94.32 | -44.92 | 36.89 | 86.28 | 209.16 |
Interest Expense | - | - | -21.03 | -23.11 | -27.42 | -35.24 |
Interest & Investment Income | - | - | 4.24 | 8.37 | 11.97 | 40.87 |
Currency Exchange Gain (Loss) | - | - | 1.1 | 0.62 | 5.41 | -1.63 |
Other Non Operating Income (Expenses) | -61.83 | -61.34 | -1.53 | -52.21 | -36.24 | -29.15 |
EBT Excluding Unusual Items | -164.8 | -155.66 | -62.14 | -29.43 | 40 | 184.02 |
Impairment of Goodwill | - | - | - | -22.34 | -10.08 | -13.09 |
Gain (Loss) on Sale of Investments | -0.01 | -0.01 | - | - | - | -2.76 |
Gain (Loss) on Sale of Assets | -0.07 | -0.07 | -1.73 | -1.67 | -0.24 | -6.38 |
Asset Writedown | -76.93 | -78.21 | - | - | - | - |
Legal Settlements | - | - | - | - | - | 11.27 |
Other Unusual Items | - | - | -2.58 | 4.28 | 13.25 | 1.42 |
Pretax Income | -241.8 | -233.95 | -66.46 | -49.16 | 42.94 | 174.48 |
Income Tax Expense | 17.57 | 12.87 | -10.33 | 0.04 | 16.82 | 36.43 |
Earnings From Continuing Operations | -259.37 | -246.82 | -56.13 | -49.2 | 26.12 | 138.05 |
Minority Interest in Earnings | 1.5 | 1.24 | -3.58 | -16.28 | 8.33 | 9.47 |
Net Income | -257.87 | -245.58 | -59.71 | -65.48 | 34.46 | 147.52 |
Net Income to Common | -257.87 | -245.58 | -59.71 | -65.48 | 34.46 | 147.52 |
Net Income Growth | - | - | - | - | -76.64% | 2206.02% |
Shares Outstanding (Basic) | 538 | 523 | 543 | 546 | 492 | 476 |
Shares Outstanding (Diluted) | 538 | 523 | 543 | 546 | 492 | 476 |
Shares Change (YoY) | 1.11% | -3.74% | -0.52% | 10.86% | 3.43% | 6.37% |
EPS (Basic) | -0.48 | -0.47 | -0.11 | -0.12 | 0.07 | 0.31 |
EPS (Diluted) | -0.48 | -0.47 | -0.11 | -0.12 | 0.07 | 0.31 |
EPS Growth | - | - | - | - | -77.42% | 2067.83% |
Free Cash Flow | -70.8 | -56.57 | -49.03 | -9.02 | 8.54 | -7.25 |
Free Cash Flow Per Share | -0.13 | -0.11 | -0.09 | -0.02 | 0.02 | -0.01 |
Dividend Per Share | - | - | - | - | 0.020 | 0.064 |
Dividend Growth | - | - | - | - | -68.90% | - |
Gross Margin | 29.90% | 31.05% | 36.04% | 42.35% | 46.13% | 47.87% |
Operating Margin | -15.41% | -13.75% | -5.79% | 4.12% | 10.31% | 19.04% |
Profit Margin | -38.60% | -35.80% | -7.70% | -7.32% | 4.12% | 13.43% |
Free Cash Flow Margin | -10.60% | -8.25% | -6.32% | -1.01% | 1.02% | -0.66% |
EBITDA | -1.14 | 6.94 | 54.05 | 127.17 | 161.17 | 287.55 |
EBITDA Margin | -0.17% | 1.01% | 6.97% | 14.22% | 19.25% | 26.18% |
D&A For EBITDA | 101.83 | 101.26 | 98.98 | 90.27 | 74.89 | 78.39 |
EBIT | -102.97 | -94.32 | -44.92 | 36.89 | 86.28 | 209.16 |
EBIT Margin | -15.41% | -13.75% | -5.79% | 4.12% | 10.31% | 19.04% |
Effective Tax Rate | - | - | - | - | 39.17% | 20.88% |
Revenue as Reported | - | - | 775.73 | 894.51 | 837.24 | 1,098 |
Advertising Expenses | - | - | 126.41 | 146.44 | 132.09 | 144.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.